Aminov Erez

Aminov Erez is listed in filings as CEO and Chairman at Telomir Pharmaceuticals, Inc. Common Stock. This profile follows SEC Form 4 activity through May 22, 2026, including sale activity. Recent filings connect the profile to Telomir Pharmaceuticals, Inc. Common Stock (TELO) and MIRA Pharmaceuticals, Inc. (MIRA). The current snapshot covers public activity from Nov 27, 2024 to May 22, 2026. Reported amounts are shown as $4.2M to $56.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.